ProvectAI
PrivateLast Round
Seed
Nov 21, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ProvectAI operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Seed round in November 2024.
ProvectAI is a health technology company developing a 2D-to-3D transformation engine to enhance intraoperative surgical imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Medical Devices, Computer Vision
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProvectAI Comparables
Compare ProvectAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Body Vision Medical | 73% | |
| Pulmera Inc. | 73% | |
| Radlink, Inc. | 70% |
For institutional investors. Book with your work email.
ProvectAI Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ProvectAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arteria Capital | Seed |
| Newfund Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 235% MoM.
- Jul 28, 2026
Grew 300% QoQ from 1 to 4 employees.
For institutional investors. Book with your work email.
ProvectAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProvectAI's valuation, stock price, and market status.
Is ProvectAI a public or private company?
ProvectAI is a private company.
What is the current stock price of ProvectAI?
ProvectAI is a private company, so its shares have no public market price. Caplight tracks ProvectAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProvectAI worth (valuation)?
Valuation information for ProvectAI is not publicly available.
Can I buy ProvectAI stock?
ProvectAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProvectAI's last funding round?
ProvectAI's most recent funding round was Seed on November 21, 2024.
Who are the main investors in ProvectAI?
Key investors in ProvectAI include Arteria Capital, Newfund Capital.
Will ProvectAI IPO soon?
No public IPO plans have been announced for ProvectAI.
How can I track ProvectAI secondary market activity?
Caplight tracks bids, offers, and trades in ProvectAI's shares on secondary markets.